发明名称 Acetamidderivater, fremgangsmåde til fremstilling deraf og medicinske præparater
摘要 <p>Acetamide derivatives represented by general formula (I) and physiologically acceptable acid-addition salts thereof, wherein X represents -O- or -NR4; R1 represents H, lower alkyl, lower alkenyl or cycloalkyl(lower)alkyl; R2 represents lower alkyl, cycloalkyl, optionally substituted phenyl, etc.; R3 represents H, lower alkyl or hydroxy(lower)alkyl; R4 represents H, lower alkyl, etc.; R5 represents H, lower alkyl, lower alkenyl, hydroxy(lower)alkyl, etc.; R6 represents H, lower alkyl, CF3 or optionally substituted phenyl, or R5 and R6 together form -(CH2)n-; R7 represents H, halogeno, lower alkyl, lower alkoxy, CF3, OH, NH2, etc.; and R8 represents H, halogeno, lower alkyl or lower alkoxy. The compounds act selectively on the peripheral BZ omega 3 receptor and exhibit excellent pharmocological effects, which makes them useful as a remedy and preventive for central diseases, for example, diseases associated with anxiety, depression and epilepsy, etc. <CHEM></p>
申请公布号 DK0826673(T3) 申请公布日期 2003.03.24
申请号 DK19960909327T 申请日期 1996.04.10
申请人 DAINIPPON PHARMACEUTICAL CO., LTD. 发明人 MURATA, TERUYA;HINO, KATSUHIKO;FURUKAWA, KIYOSHI;OKA, MAKOTO;ITOH, MARI
分类号 A61K31/505;A61K31/506;A61P25/08;A61P37/02;C07D239/34;C07D239/36;C07D239/42;C07D239/90;C07D239/91;C07D239/94;C07D403/12;(IPC1-7):C07D239/34;C07D239/70;C07D401/04;C07D401/12;C07D405/12;C07D403/14 主分类号 A61K31/505
代理机构 代理人
主权项
地址